Tyler concentrates his practice in the chemical, pharmaceutical and biotechnological arts. Tyler’s in-depth experience in biochemistry gives him unique insight into various types of patentable products and processes, particularly in the health and biosciences sector. His areas of focus include:
- Vaccines (including flaviviruses (e.g. dengue, Zika, yellow-fever etc.) alphaviruses (e.g. chikungunya, Eastern equine encephalitis etc.), enterovirus and poxvirus)
- Vaccine compositions and methods for administration
- Stem cells and stem cell therapy
- Collagens and microgels
- Small molecule pharmaceuticals and biologics
- Drug targeting/delivery systems
- Plant genetics and GMO traits
- Insecticides, fungicides and herbicides
- Transplantation and ischemia/reperfusion injury
- Gene editing and CRISPR technology
Biosciences Research Experience
Before attending law school, Tyler served as a post-doctoral research fellow at University of Toronto, where his research focused on regulation of SHP-2, a tyrosine phosphatase, related pathways in various types of human cancers and down syndromes. His experience includes developing and analyzing mammalian stem cell and genetically modified mouse model systems.
Tyler earned his Ph.D. at Queen's University in Canada, where he identified a new role of LDL-like lipoproteins and apolipoproteins in various cardiovascular diseases.